Under Crowston’s leadership, which began in 2009, CERA has broadened the scope of its work to include the restoration of lost vision, while it also undertook two International Reviews of its research, governance and strategy.“I am proud of the work we have done over the past decade in creating an exceptional basic science program to complent our clinical and population health research capacity, attracting world-class researchers to join us in tackling eye disease,” Crowston said.{{quote-a:r-w:400-I:2-Q: I am delighted at the prospect of spending more time in the laboratory, trying to unlock the key to understanding glaucoma and helping restore sight to the hundreds of thousands of Australians. -WHO:Jonathan Crowston, CERA managing director}}“In doing so, we have broadened the scope of our research beyond better treatments and earlier diagnosis to the restoration of lost vision, which has led to the development of our three strategic research thes; Ageing eye disease, vision regeneration, and products and pathways to patients.In addition to stepping away from his duties as CERA managing director, Crowston will also relinquish his position as Ringland Anderson Professor of Opthalmology at the University of Melbourne. In announcing his decision, Crowston reiterated his personal commitment to continuing with his clinical and research interests at CERA.“I am delighted at the prospect of spending more time in the laboratory, trying to unlock the key to understanding glaucoma and helping restore sight to the hundreds of thousands of Australians affected by this disease,” he said.“I want to thank everyone who has supported CERA so far on our journey to becoming Australia’s leading eye research centre; a place where clinicians, patients, researchers and industry come together to develop treatments and technologies that transform lives. With your help, we can continue to give more people with eye disease a chance to save or restore their sight.”CERA has commenced a global search and recruitment process to fill the position and an announcent is expected in the coming months.
Gene therapy trial brings dramatic improvement in eyesight for patients
Patients with a rare inherited disease affecting their sight have experienced quick, sometimes substantial vision improvements after being involved in...